Trials / Conditions / ICC
ICC
6 registered clinical trials studyying ICC — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC NCT07364305 | Eastern Hepatobiliary Surgery Hospital | Phase 2 |
| Not Yet Recruiting | Combining Chemoradiotherapy With Sintilimab in First-Line ICC NCT06447454 | Shanghai Zhongshan Hospital | — |
| Unknown | Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis NCT04769908 | Sun Yat-sen University | Phase 2 |
| Withdrawn | Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC NCT04682249 | Sun Yat-sen University | Phase 2 |
| Withdrawn | Systemic Chemotherapy Plus PD-1 for Metastasis ICC NCT04398927 | Sun Yat-sen University | Phase 2 |
| Unknown | Treatment of Advanced Intrahepatic Cholangiocarcinoma NCT03940378 | The First Affiliated Hospital of Zhengzhou University | Phase 3 |